 |
|
|||||||||||||||||||||||||||||||||
| [發表評論] [本類其他產品] [本類其他供應商] [收藏] | ||||||||||||||||||||||||||||||||||
| 銷售商： 杭州華安生物技術有限公司 | 查看該公司所有產品 >> |
Fig1: Western blot analysis of RALA on human RALA recombinant protein using anti-RALA antibody at 1/1,000 dilution.
Fig2: Western blot analysis of RALA on HEK293 (1) and RALA-hIgGFc transfected HEK293 (2) cell lysate using anti-RALA antibody at 1/1,000 dilution.
Fig3: Western blot analysis of RALA on different cell lysate using anti-RALA antibody at 1/1,000 dilution. Positive control： Lane1: HepG2 Lane2: MCF-7 Lane3: A549 Lane4: K562 Lane5: Raji Lane6: MOLT4 Lane7: Hela Lane8: COS7 Lane9: NIH/3T3
Fig4:ICC staining RALA (green) and Actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Fig5: Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue using anti-RALA antibody. Counter stained with hematoxylin.
Fig6: Immunohistochemical analysis of paraffin-embedded human bladder cancer tissue using anti-RALA antibody. Counter stained with hematoxylin.
Fig7:Flow cytometric analysis of MCF-7 cells with RALA antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).
如有售后問題可及時聯系我們，我們會有售后人員為您解決問題，聯系電話0571-89986345。
手機版：RALA 鼠單克隆抗體
Copyright(C) 1998-2025 生物器材網 電話：021-64166852;13621656896 E-mail：info@bio-equip.com